Deferasirox Tablet, Film Coated
Product Images NDC 70771-1471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 70771-1471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1590cfec 1c93 4511 9115 566b30176b36 03

1590cfec 1c93 4511 9115 566b30176b36 03
This is a medication package label for Deferasirox tablets giving the NDC code, dosage information, and storage instructions. The package includes 30 tablets of 90mg each and is resistant to damage with protection from moisture required. The pharmacist is advised to dispense a Medication Guide and keep drugs out of reach of children. The manufacturing company is Zydus Reonly.*
FDA Label Image

1590cfec 1c93 4511 9115 566b30176b36 04

FDA Label Image

1590cfec 1c93 4511 9115 566b30176b36 05

1590cfec 1c93 4511 9115 566b30176b36 05
This is a package label for 30 tablets of Deferasirox iz used for treatment of various diseases. The tablets are child-resistant and should be stored at a temperature of 25°C with protection from moisture. The manufacturer is CadlaHeatharo and the product is provided separately to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.